These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2896916)

  • 1. Enoximone.
    Lancet; 1988 May; 1(8594):1085-6. PubMed ID: 2896916
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of heart failure with enoximone, a new phosphodiesterase inhibitor. Düsseldorf, Federal Republic of Germany. September 25-27, 1987. Proceedings.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S1-S83. PubMed ID: 2480479
    [No Abstract]   [Full Text] [Related]  

  • 3. [Enoximone].
    Ventura G
    Medicina (Firenze); 1990; 10(2):191-3. PubMed ID: 2148796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT; Janicki JS; Jain MC
    J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enoximone in chronic heart failure.
    Swan HJ
    Circulation; 1990 Sep; 82(3):1049-50. PubMed ID: 2144215
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
    Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
    Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Feb; 314(6):349-58. PubMed ID: 2418353
    [No Abstract]   [Full Text] [Related]  

  • 9. Enoximone in intensive care. Proceedings of a symposium. Brussels, Belgium, 21st March 1988.
    Br J Clin Pract Suppl; 1988 Dec; 64():1-87. PubMed ID: 2978495
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial haemodynamic effects of enoximone in cardiac transplant candidates awaiting a suitable donor.
    Vulser C; Guillemain R; Amrein C; Trinquier R; Farge D; Dreyfus G; Couetil JP; Carpentier A; Cousin MT
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):11. PubMed ID: 2535300
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term therapy of chronic cardiac insufficiency using enoximone].
    Treese N; Erbel R; Rhein S; Diefenbach C; Alken RG; Mohr-Kahaly S; Meyer J
    Dtsch Med Wochenschr; 1987 Jul; 112(30):1163-9. PubMed ID: 2956080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cardiovascular effects of dobutamine and enoximone in treatment of low cardiac output syndrome after valvular surgery--preliminary results.
    George M; Lehot JJ; Bastien O; Durand PG; Estanove S
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):12. PubMed ID: 2535301
    [No Abstract]   [Full Text] [Related]  

  • 13. Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment.
    Dubourg O; Delorme G; Hardy A; Beauchet A; Tarral A; Bourdarias JP
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S33-42; discussion S43. PubMed ID: 2145237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of enoximone on quality of life.
    Baligadoo SJ; Subratty H; Manraz M; Tarral A; Maiti D; Murday M
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S29-32. PubMed ID: 2145235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolerance of enoximone in patients with heart failure].
    Gilfrich HJ; Dieterich HA
    Z Kardiol; 1991; 80 Suppl 4():93-7. PubMed ID: 1833904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential hemodynamic effects of oral enoximone in severe congestive heart failure.
    Murali S; Uretsky BF; Betschart AR; Tokarczyk TR; Kolesar JA; Reddy PS
    Am J Cardiol; 1990 Feb; 65(7):515-9. PubMed ID: 2137668
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrophysiologic effects of enoximone in patients with congestive heart failure.
    Hohnloser SH; Zehender M; Geibel A; Meinertz T; Just H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S29-32. PubMed ID: 2480482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F; Peters P; Schneider M
    Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic effects of enoximone--comparative studies of heart surgery patients].
    Boldt J; Hempelmann G
    Z Kardiol; 1991; 80 Suppl 4():41-6. PubMed ID: 1833896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enoximone improves selection of candidates for urgent cardiac transplantation.
    Loisance D; Benvenuti C; Dubois Randé JL; Deleuze P; Castaigne A; Cachera JP
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S23-7. PubMed ID: 2145234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.